envarsus 1 mg retardtabletten - op60
chiesi farmaceutici s.p.a. (3198853) - tacrolimus 1 h<2>o - retardtablette - tacrolimus 1 h<2>o (32463) 1,02 milligramm
envarsus 0,75 mg retardtabletten - op30
chiesi farmaceutici s.p.a. (3198853) - tacrolimus 1 h<2>o - retardtablette - tacrolimus 1 h<2>o (32463) 0,765 milligramm
envarsus 4 mg retardtabletten - op60
chiesi farmaceutici s.p.a. (3198853) - tacrolimus 1 h<2>o - retardtablette - tacrolimus 1 h<2>o (32463) 4,08 milligramm
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastische mittel - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastische mittel - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
gefrorenes frischplasma (hdz nrw), mit cpd
herz- und diabeteszentrum nrw institut f laboratoriums- und transfusionsmedizin (3350108) - gerinnungsaktives plasma vom menschen - infusionslösung - teil 1 - infusionslösung; gerinnungsaktives plasma vom menschen (10676) 0,75 milliliter pro milliliter
fdg-hdz
herz- und diabeteszentrum nordrhein-westfalen universitätsklinik der ruhr-universität bochum krankenhausbetriebsges. bad oeynhausen mbh (8079656) - fludeoxyglucose ((18)f) - injektionslösung - teil 1 - injektionslösung; fludeoxyglucose ((18)f) (24991) 40 megabecquerel
human-blutkonserve-vollblut ab rh pos.
st.-willibrord-spital emmerich-rees ggmbh [hist] blutspendedienst niederrhein-westfalen - erythrozyten vom menschen - infusionslösung - erythrozyten vom menschen 200.ml
human-blutkonserve-vollblut 0 rh pos.
st.-willibrord-spital emmerich-rees ggmbh [hist] blutspendedienst niederrhein-westfalen - blutplasma vom menschen, erythrozyten vom menschen - infusionslösung - blutplasma vom menschen 0.0x x x; erythrozyten vom menschen 200.ml
human-blutkonserve-vollblut ab rh neg.
st.-willibrord-spital emmerich-rees ggmbh [hist] blutspendedienst niederrhein-westfalen - blutplasma vom menschen, erythrozyten vom menschen - infusionslösung - blutplasma vom menschen 0.0x x x; erythrozyten vom menschen 200.ml